Joe DePinto

Joe has spent the past 30 years focused on bringing life-saving specialty drugs to market, helping patients with complex diseases to access advanced care, and developing future leaders in the healthcare industry. Joe is a passionate leader with a commitment to mentorship and building strong, diverse teams. Joe was the first male National Board member of the Healthcare Businesswomen’s Association. Joe’s experience includes operations globally for multiple biotech, pharma, distribution, professional services, and technology companies. He is recognized for consistently delivering multi-million-dollar revenue gains in highly competitive marketplaces. His core leadership competencies include leading all aspects of strategy, drug development, investor relations, and commercialization with multiple global launches. Most recently, Joe served as Chief Commercial Officer at Vineti, a venture-based technology start-up focused on industrializing the value chain for personalized therapies. His past roles have also included leadership positions at top pharmaceutical companies, Johnson & Johnson and Lilly. Joe also previously served as the President of Cardinal Health Specialty Solutions, EVP Chief Commercial Officer at Sunesis Pharmaceuticals, EVP Global Commercial Operations at Dendreon, VP Global Commercial Operations at ImClone, and VP at Abraxis Oncology. Joe has been published in multiple publications on cell and gene therapy, including Cell & Gene Therapy Insights and PharmaVoice. Joe was also recognized as one of the top 100 pharmaceutical executives by PharmaVoice in 2017 and 2024. Joe’s academic credentials include a BS in Marketing and an MBA, with an emphasis on Pharmaceutical/Chemical Studies.